5月27日中新集团旗下中新资本已投企业派格生物在港交所上市(股票代码:2565.HK)派格生物此次全球发售1928.35万股,募集资金约3.01亿港元,将用于PB-119商业化及适应症扩展、PB-718的进一步开发、其他管线候选产品研发、业务开发及营运资金等。派格生物成立于2008年,是一家专注于自主研究及开发慢性病创新疗法的生物技术公司,重点关注内分泌代谢领域。公司利用自主开发的HECTOR™...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.